SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer
Novel Vaccine Company Expands Leadership Team and Establishes US Presence OXFORD, England & CAMBRIDGE, Mass.–(BUSINESS WIRE)–SpyBiotech, a British biotechnology company with a novel vaccine platform technology that can target infectious diseases, cancer, and chronic diseases, has appointed Mark Leuchtenberger as its Chief Executive Officer (CEO). He also joins the Board of Directors. Sumi Biswas, the … [Read more…]